Discovery and Life Sciences

Proteomics, metabolomics, lipidomics, and other Omics disciplines are changing Discovery and Life Sciences research. LC/MS studies continue to catalyze profound changes in our understanding of biology. It's no longer possible to fully understand biological systems by studying their parts; now systems biology has merged these once disparate data streams to gain a holistic understanding of complex organisms and disease states — and the opportunity to design broad-spectrum or targeted therapies.

The convergence of Omics
Whether it's top-down or bottom-up analyses; targeted or untargeted studies; structural work to identify and confirm metabolites; or spatial localization of metabolites in biological tissues, Waters state-of-the-art LC, MS, and informatics solutions tie together systems, information, and scientists to help you uncover insights earlier than ever before.

Waters' knowledge-driven approach to Discovery and Life Sciences has proven to significantly impact the quality of research and analyses of targets and compounds that start the journey of a molecule.

Health Sciences

• Discovery Research — Proteomics, biomarker identification, TransOmics Platform Solution, Omics, metabolomics, lipidomics, MALDI imaging
• Translational and Clinical Research — Biomarker validation, clinical research
• Clinical Diagnostics — MassTrak Immunosuppressants Kit
• Clinical Systems — Toxicology, MassTrak Online SPE Analyzer
• Forensic Toxicology — Screening, confirmation analysis

 Discovery

• Medicinal Chemistry — Take advantage of orthagonal chromatography using both UPLC and UPC² to know more about your compound during screening